Thoracic Cancer Beyond the Clinic - Community Impacts
Covid-19 rapidly affected our lives and the life of our patients. Vaccination campaign started in 2021. At least four types of vaccines are widely used in the US (Pfizer, Moderna, Johnson and Johnson and Astra Zeneca).
Category
  • Lung Cancer
Format
  • CME only
Credits
  • AMA PRA Category 1 Credit™
  • Certificate of Attendance
Peri-operative Therapy in Thoracic Cancer
The course presents a review of recent changes in the management of resected NSCLC as well as the management of patients with early stage NSCLC treated with SBRT. The four main topics are:
Category
  • Lung Cancer
Format
  • CME only
Credits
  • AMA PRA Category 1 Credit™
  • Certificate of Attendance
Stage III Thoracic Cancer Debates
The course consists of two debates. The first debate consists of two thoracic oncologists with one arguing for the use of surgery and one against the use of surgery for patients with stage III NSCLC.
Category
  • Lung Cancer
Format
  • CME only
Credits
  • AMA PRA Category 1 Credit™
  • Certificate of Attendance
Gray Zone - Treatment for Radiation Recall Mucositis induced by Anti-PD-1 Blockade
The ultimate goal of radiation oncology research is to improve clinical care.  As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.  But despite our best efforts, evidence-based medicine cannot provide 1 clear
Category
  • Lung Cancer
Format
  • Gray Zone
Credits
  • AMA PRA Category 1 Credit™
Lung Cancer/Thoracic Malignancies Science Highlights
This session highlights six of the most clinically relevant abstracts within the Lung Cancer/Thoracic Malignancies track of the 2022 ASTRO Annual Meeting Scientific Program.
Category
  • Lung Cancer
Format
  • CME only
Credits
  • AMA PRA Category 1 Credit™
  • Certificate of Attendance
Predictors of Pneumonitis in Patients with Locally Advanced Non-small Cell Lung Cancer Treated with Definitive Chemoradiation Followed by Consolidative Durvalumab
This journal activity provides practitioners with the knowledge for practice improvement in treating patients with non-small cell lung cancer undergoing definitive chemoradiation followed by consolidative durvalumab.
Category
  • Lung Cancer
Format
  • CME only
Credits
  • AMA PRA Category 1 Credit™
  • Certificate of Attendance